Delivery Order SPE2DB24D2205-SPE2DB25FECBY

Award Date 5/8/25
Potential Completion Date 5/9/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,466.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, with a performance period ending on April 21, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,261.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, with an ultimate completion date of April 18, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract, indicating open...
This federal contract award, valued at $1,407.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 27, 2025. The contract covers the procurement of 4567039307 AMNESTEEM 40 MG CAPSULE 30S, which are likely pharmaceutical products. Amerisourcebergen holds a significant Indefinite...
This federal contract award, valued at $2,712.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a medical product, and has a period of performance through February 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,758.32, is a Delivery Order with a Firm Fixed Price pricing type. The contract is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a medical product, with a period of performance through March 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $4,237.80 from the Defense Logistics Agency (DLA) for the supply of AMNESTEEM 40 MG CAPSULE 30S medical products. The contract has an ultimate completion date of March 7, 2025 and a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This federal contract award, valued at $4,322.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through March 5, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,563.85 Firm Fixed Price Delivery Order contract covers the provision of AMNESTEEM 40 MG CAPSULE 30S, a generic pharmaceutical product. The contract has an ultimate completion date of January 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,714.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the delivery of 4564286851 AMNESTEEM 40 MG CAPSULE 30S, with a completion date of April 16, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DOD) and Veterans Affairs (VA)...
This federal contract award, valued at $13,877.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FECBY
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,034.98, is a Firm Fixed Price Delivery Order for the supply of 4568188765 - AMNESTEEM 40 MG CAPSULE 30S. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This award supports the agency's mission to provide medical supplies and pharmaceuticals to the U.S. military and other government agencies.

Generated 8/10/25, 1:22 AM